Advertisement

Larynxkarzinom

  • J. H. A. M. Kaanders
  • T. Lenarz
  • L. A. M. Pop
  • H.-J. Schmoll
  • P. H. M. de Mulder
  • H. A. M. Marres

Zusammenfassung

Häufigkeit: Mit einem Anteil von 2–2,5% stellt das Larynxkarzinom eines der häufigsten bösartigen Geschwülste beim Mann dar; sein Anteil an den Kopf-Hals-Tumoren beträgt 40–50%.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ang KK, Kaanders JHAM, Peters LK (eds) (1994) Radiotherapy for head and neck cancers: indications and techniques. Lea & Febiger, PhiladelphiaGoogle Scholar
  2. Clavel M, Vermorken JB, Cognetti F, Cappelaere P, De Mulder PHM et al. (1994) Randomized comparison of cisplatin, methotrexate, bleomycin and vicristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC head and neck cancer cooperative group. Ann Oncol 5: 521–526Google Scholar
  3. Ferlito A (ed) (1993) Neoplasms of the larynx. Churchill Livingstone, LondonGoogle Scholar
  4. Fracchiolla NS, Pignataro L, Capaccio P et al. (1995) Multiple genetic lesions in laryngeal squamous cell carcinoma. Cancer 75: 1292–1301PubMedCrossRefGoogle Scholar
  5. Glanz H (1984) Carcinoma of the larynx. Growth, classification and grading of squamous cell carcinoma of the vocal cords. Adv Otorhinolaryngol 32: 1–32PubMedGoogle Scholar
  6. Glisson BS, Hong WK (1996) J Nat Cancer Inst 88: 567–568PubMedCrossRefGoogle Scholar
  7. Harwood AR, Hawkins NV, Beale FA, Rider WD, Ryce DP (1979) Management of advanced glottic cancer. A 10 year review of the Toronto experience. Int J Radiat Oncol Biol Phys 5: 899PubMedCrossRefGoogle Scholar
  8. Johansen LV, Overgaard J, Hjelm-Hansen M, Gadeberg CC (1990) Primary radiotherapy of T 1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Biol Phys 18: 1307PubMedCrossRefGoogle Scholar
  9. Kleinsasser O (1983) Bösartige Geschwülste des Kehlkopfes und des Hypopharynx: In: Berendes J, Link A, Zöllner F (Hrsg) Hals-Nasen-Ohrenheilkunde, 2. Aufl., Bd 2, IV/Teil 2. Thieme, StuttgartGoogle Scholar
  10. Kleinsasser O (1985) Tumors of the larynx and hypopharynx. Thieme, StuttgartGoogle Scholar
  11. Lee NK, Goepfert H, Wendt CD (1990) Supraglottic laryngectomy for intermediate-stage cancer: U.T.M.D. Anderson Cancer Center experience with combined therapy. Laryngoscope 100: 831Google Scholar
  12. Merlano M et al. (1996) J Natl Cancer Inst 88: 583–589PubMedCrossRefGoogle Scholar
  13. Million RR, Cassisi NJ (eds) (1994) Management of head and neck cancer: a multidisciplinary approach. Lippincott, PhiladelphiaGoogle Scholar
  14. Parsons JT, Mendelhall WM, Mancuso AA, Cassisi NJ, Stringer SP, Million RR (1989) Twice-a-day radiotherapy for T 3 squamous cell carcinoma of the glottic larynx. Head Neck 11: 123PubMedCrossRefGoogle Scholar
  15. Pfister DG, Harrison LB, Strong EW et al. (1995) Organ-function preservation in advanced oropharynx cancer: Results with induction chemotherapy and radiation. J Clin Oncol 13: 671–680Google Scholar
  16. Popella CH, Glanz H, Kleinsasser O (1991) Prognoserelevanz einer pT/pNKlassifikation von Larynxkarzinomen und ihre Bedeutung für die Verbesserung der TN-Klassifikation. Eur Arch Otorhinolaryngol [Suppl II]: 188–189Google Scholar
  17. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW (1991) Standardizing neck dissection terminology. Arch Otolaryngol Head Neck Surg 117: 601–605PubMedCrossRefGoogle Scholar
  18. Scholnick SB, Sun PC, Shaw ME, Haughey BH, El-Mofty SK (1994) Frequent loss of heterozygosity for Rb, TP543, and chromosome arm 3p, but not NME1 in squamous cell carcinomas of the supraglottic larynx. Cancer 73: 2472–2480PubMedCrossRefGoogle Scholar
  19. Spaulding MB, Fischer SG, Wolf GT and the Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group (1994) Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngel carcinoma. J Clin Oncol 12: 1592–1599Google Scholar
  20. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324: 1685–1690CrossRefGoogle Scholar
  21. UICC (1992) TNM classification of malignant tumours. Larynx. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  22. Wendt CD, Peters LJ, Ang KK, Morrison WH, Maor MH, Goepfert H, Oswald MH (1989) Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx. Int J Radiat Oncol Biol Phys 17: 1057PubMedCrossRefGoogle Scholar
  23. Wolfensberger M, Dort JC (1990) Endoscopic laser surgery for early glottic carcinoma: a clinical and experimental study. Laryngoscope 100: 1100PubMedCrossRefGoogle Scholar
  24. Yuen A, Medina JE, Goepfert H, Fletcher GH (1984) Management of stage T 3 and T4 glottic carcinomas. Am J Surg 148: 467PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • J. H. A. M. Kaanders
  • T. Lenarz
  • L. A. M. Pop
  • H.-J. Schmoll
  • P. H. M. de Mulder
  • H. A. M. Marres

There are no affiliations available

Personalised recommendations